Wake up Thrombolysis
Why keep fighting? 15 million strokes/year (WHO) >5 million permanently disabled >500,000 deaths Wake-up Strokes >20-25% occur during bedtime hours
Why keep fighting? 15 million strokes/year (WHO) >5 million permanently disabled >500,000 deaths Wake-up Strokes >20-25% occur during bedtime hours
Controversies in Mechanical CPR in OHCA, Epinephrine in OHCA, Bougie 1st Intubation, & Stroke Ambulances with Salim Rezaie
Alteplase is a tissue plasminogen activator used as a thrombolytic medication in: Acute Ischaemic Strokes, Acute Myocardial Infarction and PE
Stroke Thrombolysis: thrombolysis for acute ischaemic stroke is a controversial intervention; it is supported by a number of guidelines and in general is viewed favourably by the neurological community
Tenecteplase is a tissue plasminogen activator used as a thrombolytic medication in: Acute Ischaemic Strokes, Acute Myocardial Infarction, PE
Schrödinger’s Fence...or, where we currently sit on the matter of thrombolysis in Acute Stroke. An Opinion Piece on IST-3
Do we, as a global medical profession, truly know whether or not tPA is a beneficial treatment early on in the presentation of a CVA?
This is Part 1 of three posts a basic overview of thrombolysis in stroke a detailed overview of evidence based research into thrombolysis and CVA Schrödinger’s Fence Author: Prof Daniel Fatovich Let’s compare the treatment of strokes, to the treatment of…